Monday, December 23, 2024
HomeTagsPhase Ib/II Protocol

Phase Ib/II Protocol

AnBogen Therapeutics Receives Approval from U.S. FDA for Phase Ib/II Protocol Amendment for ABT-101

AnBogen Therapeutics, a clinical-stage biotech company designing and developing precision oncology therapies to improve the life of patients, announces that U.S. Food and Drug...
0FansLike
3,912FollowersFollow
0SubscribersSubscribe
spot_img

Hot Topics